Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pembrolizumab in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated with Chemotherapy
Phase: 2Phase II in Spain, 1Phase I